4Suppliers
8Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Burning Rock Biotech Limited (BNR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships
2Distinct source URLs
4High confidence
0.759Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Burning Rock Biotech Limited Suppliers

TickerNameConfidenceEvidence
GRAL GRAIL, Inc. 72% Reciprocal relationship from GRAL graph: ess tests, operate our laboratory, delay our clinical studies, and damage our relationships with our customers. We could also be exposed to potential lawsuits…
IH iHuman Inc. 72% Reciprocal relationship from IH graph: ther information on our critical accounting policies, see Note 2 to our consolidated financial statements. We believe the following accounting policies involve …
YDES YD Bio Ltd 72% Reciprocal relationship from YDES graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Nova…
YDESW YDESW 72% Reciprocal relationship from YDESW graph: Reciprocal relationship from BNR graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year…

Burning Rock Biotech Limited Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from BNR graph: ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus ha…
JNJ Johnson & Johnson 72% ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus have been endorsed by their adoption in over 20 clinical trials and studies. For e…
MS-PE Morgan Stanley 72% Reciprocal relationship from MS-PE graph: Reciprocal relationship from BNR graph: e information contained in any notice of a shareholders’ meeting received by the depositary from us. I. Subsidiary In…
MS-PK Morgan Stanley 72% e information contained in any notice of a shareholders’ meeting received by the depositary from us. I. Subsidiary Information Not applicable. 147 Table of Contents J. Annual Report to Security Holde…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: ays (1) For the year ended December 3…
MYGN Myriad Genetics, Inc. 72% ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus have been endorsed by their adoption in over 20 clinical trials and studies. For e…
YDESW YDESW 72% Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Nov…
ZTEK Zentek Ltd. 62% Reciprocal relationship from ZTEK graph: Reciprocal relationship from BNR graph: Reciprocal relationship from ZTEK graph: Reciprocal relationship from BNR graph: Reciprocal relationship from ZTEK gra…

Burning Rock Biotech Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
BNR-DEBT-8308 Warrants outstanding: 0 90% xbrl warrant detail from xbrl 2022-12-31.
BNR-DEBT-8309 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
BNR-DEBT Debt stack $6.4M 90% Market cache reports total debt of $6.4M.

Burning Rock Biotech Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Burning Rock Biotech Limited.

Burning Rock Biotech Limited Ownership

HolderNameConfidenceEvidence
BNR-OWNER-BARCLAYS-PLC BARCLAYS PLC 90% 13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders.

Burning Rock Biotech Limited Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CAPR Capricor Therapeutics, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
GRAL GRAIL, Inc. 100.00 1 ['supplier']
CSTE Caesarstone Ltd. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
🔐
BNR
Unlock BNR Supply Chain Data
Verified relationships include:
GRALGRAIL, Inc.Supplier72%
IHiHuman Inc.Supplier72%
JNJJohnson & JohnsonCustomer72%
JNJJohnson & JohnsonCustomer72%
+12 more relationships locked
Subscribe, View plans →